US Stock MarketDetailed Quotes

MNMD Mind Medicine

Watchlist
  • 6.7500
  • -0.4300-5.99%
Close Feb 25 16:00 ET
  • 6.8801
  • +0.1301+1.93%
Post 19:52 ET
494.99MMarket Cap-3.95P/E (TTM)

About Mind Medicine Company

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Company Profile

SymbolMNMD
Company NameMind Medicine
Founded2010
CEOMr. Robert B. Barrow
MarketNASDAQ
Employees57
Fiscal Year Ends12-31
AddressOne World Trade Center,Suite 8500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10007
Phone1-212-220-6633
Websitehttp://www.mindmed.co

Company Executives

  • Name
  • Position
  • Salary
  • Robert B. Barrow
  • Chief Executive Officer and Director
  • 2.14M
  • Schond L. Greenway
  • Chief Financial Officer
  • 1.14M
  • Dr. Daniel R. Karlin, M.A.,M.D.
  • Chief Medical Officer
  • 1.04M
  • Carrie F. Liao
  • Chief Accounting Officer
  • --
  • Mark R. Sullivan, J.D.
  • Chief Legal Officer and Corporate Secretary
  • --
  • Dr. Miri Halperin Wernli, PhD
  • Executive President
  • --
  • Andreas Krebs
  • Vice Chairman of the Board
  • 186.20K
  • Carol A. Vallone
  • Chairman of the Board
  • 196.20K
  • David W. Gryska, M.B.A.
  • Independent Director
  • 179.01K
  • Dr. Suzanne L. Bruhn, PhD
  • Independent Director
  • 148.70K
  • Dr. Roger Crystal, M.D.
  • Independent Director
  • 148.70K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Hunan Creator Information Technologies
300730
+20.03%
Shandong Rike Chemical
300214
+20.03%
Jiangsu LiXing General Steel Ball
300421
+20.03%
4
Jiangsu Boiln Plastics
301003
+20.00%
5
Ningbo Henghe Precision Industry
300539
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025